首页> 外文期刊>Journal of Pharmacological and Toxicological Methods >Development and characterization of LLC-PK1 cells containing Sprague-Dawley rat Abcb1a (Mdr1a): comparison of rat P-glycoprotein transport to human and mouse.
【24h】

Development and characterization of LLC-PK1 cells containing Sprague-Dawley rat Abcb1a (Mdr1a): comparison of rat P-glycoprotein transport to human and mouse.

机译:含有Sprague-Dawley大鼠Abcb1a(Mdr1a)的LLC-PK1细胞的发育和特征:大鼠P-糖蛋白向人和小鼠转运的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: P-glycoprotein is localized in numerous tissues throughout the body and plays an important role in the disposition of many xenobiotics. The contribution of P-glycoprotein-mediated drug transport is being evaluated in early drug discovery stages, particularly for compounds targeted to the central nervous system, using in vitro tools including cell lines expressing P-glycoprotein. Previous work in our laboratory suggests there are species differences in P-glycoprotein transport activity between humans and animals. The rat Abcb1a form of P-glycoprotein (formerly known as Mdr1a), the predominate isoform in the brain, has not been described in a functional cell system. Here, we describe the development and characterization of LLC-PK1 cells expressing rat Abcb1. METHODS: We cloned rat Abcb1a and generated a stable LLC-PK1 cell line. Expression and function of the cells were evaluated by immunoblot analysis, cytotoxicity analysis, cellular accumulation assays, and transcellular transport of probe substrates. The transport ratios of structurally diverse compounds obtained from parental cells or cells stably transfected with human ABCB1, mouse Abcb1a or rat Abcb1a were compared. RESULTS: Two forms of rat Abcb1a were cloned from Sprague-Dawley cDNA that differ by six amino acids and a base pair deletion. The intact form was stably transfected in LLC-PK1 cells. Immunoblot analysis demonstrated expression of the protein. The cells demonstrated P-glycoprotein-mediated function by directional transport of dexamethasone, ritonavir, and vinblastine in a transwell assay that was inhibited in the presence of cyclosporin A, verapamil, or quinidine. Likewise, the cells showed reduced cellular accumulation of Rh123 by FACS analysis that was reversed in the presence of cyclosporin A. These cells showed >or=350-fold resistance to colchicine, doxorubicin, vinblastine, and taxol and were sensitized in the presence of verapamil or cyclosporin A. Of 179 chemically diverse compounds evaluated, approximately 20% of the compounds evaluated were predicted to be substrates in one species but not in other species. DISCUSSION: Taken together, these data suggest these cells will be useful for evaluation of rat Abcb1a-mediated transport and for evaluation of species-specific P-glycoprotein-mediated transport.
机译:简介:P-糖蛋白位于人体的许多组织中,在许多异生物素的处置中起着重要作用。正在使用包括表达P-糖蛋白的细胞系在内的体外工具,在药物开发的早期阶段,特别是针对靶向中枢神经系统的化合物,评估P-糖蛋白介导的药物转运的作用。我们实验室的先前工作表明,人与动物之间的P糖蛋白转运活性存在物种差异。 P-糖蛋白(以前称为Mdr1a)的大鼠Abcb1a形式(大脑中的主要同种型)尚未在功能细胞系统中描述。在这里,我们描述了表达大鼠Abcb1的LLC-PK1细胞的发育和特征。方法:我们克隆了大鼠Abcb1a并产生了稳定的LLC-PK1细胞系。通过免疫印迹分析,细胞毒性分析,细胞蓄积分析和探针底物的跨细胞运输来评估细胞的表达和功能。比较了从亲本细胞或稳定转染人ABCB1,小鼠Abcb1a或大鼠Abcb1a的细胞中获得的结构多样的化合物的转运率。结果:从Sprague-Dawley cDNA克隆了两种形式的大鼠Abcb1a,它们的区别在于六个氨基酸和一个碱基对缺失。完整形式在LLC-PK1细胞中稳定转染。免疫印迹分析证明了该蛋白的表达。该细胞通过地塞米松,利托那韦和长春花碱的定向转运,在transwell测定中表现出P-糖蛋白介导的功能,在存在环孢菌素A,维拉帕米或奎尼丁的情况下被抑制。同样,通过FACS分析,细胞显示Rh123的细胞积累减少,而在环孢菌素A存在下逆转。这些细胞对秋水仙碱,阿霉素,长春碱和紫杉醇的抵抗力大于或等于350倍,并且在维拉帕米存在下敏化在179种化学上不同的化合物中,预计约20%的化合物是一种物种的底物,而不是其他物种的底物。讨论:总的来说,这些数据表明这些细胞将有助于评估大鼠Abcb1a介导的运输和物种特异性P糖蛋白介导的运输。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号